PEOPLE People By Staff Monday, July 18, 2016 12:00 AM Mike Daley Industry Veteran and The Vision Council CEO Mike Daley to Retire in Late 2016 ALEXANDRIA, Va.—Industry veteran Mike Daley, chief executive officer of The Vision Council, has announced that he will retire in late 2016. The statement from The Vision Council noted, “For over two years, Daley’s leadership of The Vision Council has produced a renewed strategic focus on the International Vision Expos East and West to provide attendees and exhibitors with the best possible educational and sales opportunities, and has continued the shepherding of the Think About Your Eyes industry campaign which continues to grow eye exams and increase sales, adding multiple new industry partners and state optometric associations. He has overseen the development of a new organizational vision, strengthened the mission and set specific, ambitious goals to better serve the needs of members and grow the industry at large.” “It has been my sincere pleasure to lead The Vision Council over the last two years, and witness the many accomplishments of the organization,” Daley said. “I have spent my entire career working with and for the optical industry, and am tremendously proud of all the work that The Vision Council has done and continues to do on behalf of the industry that has given me my career.” A longtime optical industry veteran, Daley began his optical career as an instructor with Ferris State University in 1975. After 34 years with Essilor he retired in 2008 as the president and COO of the organization’s lens division. To advance the optical community, Daley has served as a board member or in a leadership position for a number of optical organizations including Optometry Cares - the American Optometric Association Foundation, Prevent Blindness America, The Illinois College of Optometry board of trustees, and served as a former director of the Foundation for Eye Health Awareness. His tenure with The Vision Council included the roles of chairman of the board of directors, liaison to the Lab Division, and finally the organization’s CEO. Most recently, he was honored with the 2016 ASCO Industry Leadership Award. “Mike is one of the most respected professionals in the eyecare industry, and it has been a pleasure to work with him throughout his time at The Vision Council,” said Marty Bassett, chairman of The Vision Council board of directors. “His leadership has helped to increase the visibility of organizations offering vision care products and services, and raises the tide of the industry as a whole.” The Vision Council is conducting a thorough search to select a new CEO. Inquiries may be sent to Donna Jones, senior director of human resources, at djones@thevisioncouncil.org or (703) 548-6782. Mark M. Sieczkarek NovaBay Pharmaceuticals Names Mark M. Sieczkarek President and CEO EMERYVILLE, Calif.—NovaBay Pharmaceuticals has appointed Mark M. Sieczkarek as president and chief executive officer, effective June 13. Sieczkarek has been a NovaBay director since January 2014, was named chairman in April 2015 and has served as interim president and CEO since November 2015. He has been instrumental in the development and implementation of the go-to-market strategy for Avenova, the company’s proprietary lid and lash cleaner. Sieczkarek previously was CEO of Solta Medical (acquired by Valeant Pharmaceuticals) and of Conceptus (acquired by Bayer HealthCare). Prior to that, he was senior vice president and president of the Americas and Europe for Bausch + Lomb (acquired by Valeant Pharmaceuticals), where he was responsible for overseeing multinational commercial launches of several leading products. David A. Hollander Ora Names David A. Hollander, MD, Chief Medical Officer and SVP BOSTON—Ora, Inc., a leading partner for ophthalmic pharmaceutical and device development, has appointed David A. Hollander, MD, as chief medical officer and senior vice president. Dr. Hollander most recently served as therapeutic area head and vice president of clinical development at Allergan, responsible for global strategy and clinical development programs in anterior segment ophthalmology and consumer eyecare. “Ora’s technology, operational approach, and talented team have been critical to building our reputation for excellence. The perspective, experience, and skills that Dr. Hollander brings to Ora will enhance our ability to deliver exceptional value to every phase of our clients’ development programs, large and small,” said Ora’s president and CEO, Stuart B. Abelson. Dr. Hollander joined Allergan in 2006 as a medical director in ophthalmology and held positions of increasing responsibility, including vice president of eyecare for U.S. medical affairs, and global head of eyecare for global medical affairs. Founded by Harvard professor of ophthalmology and surgeon, Dr. Mark Abelson, Ora’s mission for over 35 years has been to improve the quality and reproducibility of clinical research in ophthalmology.